J-Codes
J2000–J2999: Drugs Administered Other than Oral Method
J2000–J2999
- J2001Injection, lidocaine hcl for intravenous infusion, 10 mg
- J2002Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003Injection, lidocaine hydrochloride, 1 mg
- J2004Injection, lidocaine hcl with epinephrine, 1 mg
- J2010Injection, lincomycin hcl, up to 300 mg
- J2020Injection, linezolid, 200 mg
- J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060Injection, lorazepam, 2 mg
- J2062Loxapine for inhalation, 1 mg
- J2150Injection, mannitol, 25% in 50 ml
- J2151Injection, mannitol, 250 mg
- J2170Injection, mecasermin, 1 mg
- J2175Injection, meperidine hydrochloride, per 100 mg
- J2180Injection, meperidine and promethazine hcl, up to 50 mg
- J2182Injection, mepolizumab, 1 mg
- J2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185Injection, meropenem, 100 mg
- J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
- J2210Injection, methylergonovine maleate, up to 0.2 mg
- J2212Injection, methylnaltrexone, 0.1 mg
- J2246Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
- J2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
- J2248Injection, micafungin sodium, 1 mg
- J2249Injection, remimazolam, 1 mg
- J2250Injection, midazolam hydrochloride, per 1 mg
- J2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253Injection, midazolam (seizalam), 1 mg
- J2260Injection, milrinone lactate, 5 mg
- J2265Injection, minocycline hydrochloride, 1 mg
- J2267Injection, mirikizumab-mrkz, 1 mg
- J2270Injection, morphine sulfate, up to 10 mg
- J2271Injection, morphine sulfate, 100mg
- J2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
- J2274Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- J2275Injection, morphine sulfate (preservative-free sterile solution), per 10 mg
- J2277Injection, motixafortide, 0.25 mg
- J2278Injection, ziconotide, 1 microgram
- J2280Injection, moxifloxacin, 100 mg
- J2281Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
- J2290Injection, nafcillin sodium, 20 mg
- J2291Injection, nafcillin sodium (baxter), 20 mg
- J2300Injection, nalbuphine hydrochloride, per 10 mg
- J2305Injection, nitroglycerin, 5 mg
- J2310Injection, naloxone hydrochloride, per 1 mg
- J2311Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315Injection, naltrexone, depot form, 1 mg
- J2320Injection, nandrolone decanoate, up to 50 mg
- J2323Injection, natalizumab, 1 mg
- J2325Injection, nesiritide, 0.1 mg
- J2326Injection, nusinersen, 0.1 mg
- J2327Injection, risankizumab-rzaa, intravenous, 1 mg
- J2329Injection, ublituximab-xiiy, 1mg
- J2350Injection, ocrelizumab, 1 mg
- J2351Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq
- J2353Injection, octreotide, depot form for intramuscular injection, 1 mg
- J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
- J2355Injection, oprelvekin, 5 mg
- J2356Injection, tezepelumab-ekko, 1 mg
- J2357Injection, omalizumab, 5 mg
- J2358Injection, olanzapine, long-acting, 1 mg
- J2359Injection, olanzapine, 0.5 mg
- J2360Injection, orphenadrine citrate, up to 60 mg
- J2361Injection, depemokimab-ulaa, 1 mg
- J2370Injection, phenylephrine hcl, up to 1 ml
- J2371Injection, phenylephrine hydrochloride, 20 micrograms
- J2372Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
- J2373Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
- J2374Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml
- J2400Injection, chloroprocaine hydrochloride, per 30 ml
- J2401Injection, chloroprocaine hydrochloride, per 1 mg
- J2402Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404Injection, nicardipine, 0.1 mg
- J2405Injection, ondansetron hydrochloride, per 1 mg
- J2406Injection, oritavancin (kimyrsa), 10 mg
- J2407Injection, oritavancin (orbactiv), 10 mg
- J2410Injection, oxymorphone hcl, up to 1 mg
- J2425Injection, palifermin, 50 micrograms
- J2426Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg
- J2430Injection, pamidronate disodium, per 30 mg
- J2440Injection, papaverine hcl, up to 60 mg
- J2460Injection, oxytetracycline hcl, up to 50 mg
- J2468Injection, palonosetron hydrochloride (posfrea), 25 micrograms
- J2469Injection, palonosetron hcl, 25 mcg
- J2470Injection, pantoprazole sodium, 40 mg
- J2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
- J2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
- J2501Injection, paricalcitol, 1 mcg
- J2502Injection, pasireotide long acting, 1 mg
- J2503Injection, pegaptanib sodium, 0.3 mg
- J2504Injection, pegademase bovine, 25 iu
- J2505Injection, pegfilgrastim, 6 mg
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507Injection, pegloticase, 1 mg
- J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2513Injection, pentastarch, 10% solution, 100 ml
- J2515Injection, pentobarbital sodium, per 50 mg
- J2516Injection, pentamidine isethionate, 1 mg
- J2540Injection, penicillin g potassium, up to 600,000 units
- J2543Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
- J2545Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
- J2547Injection, peramivir, 1 mg
- J2550Injection, promethazine hcl, up to 50 mg
- J2560Injection, phenobarbital sodium, up to 120 mg
- J2561Injection, phenobarbital sodium (sezaby), 1 mg
- J2562Injection, plerixafor, 1 mg
- J2590Injection, oxytocin, up to 10 units
- J2596Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit
- J2597Injection, desmopressin acetate, per 1 mcg
- J2598Injection, vasopressin, 1 unit
- J2599Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit
- J2601Injection, vasopressin (baxter), 1 unit
- J2650Injection, prednisolone acetate, up to 1 ml
- J2670Injection, tolazoline hcl, up to 25 mg
- J2675Injection, progesterone, per 50 mg
- J2679Injection, fluphenazine hcl, 1.25 mg
- J2680Injection, fluphenazine decanoate, up to 25 mg
- J2690Injection, procainamide hcl, up to 1 gm
- J2700Injection, oxacillin sodium, up to 250 mg
- J2704Injection, propofol, 10 mg
- J2710Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720Injection, protamine sulfate, per 10 mg
- J2724Injection, protein c concentrate, intravenous, human, 10 iu
- J2725Injection, protirelin, per 250 mcg
- J2730Injection, pralidoxime chloride, up to 1 gm
- J2760Injection, phentolamine mesylate, up to 5 mg
- J2765Injection, metoclopramide hcl, up to 10 mg
- J2770Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777Injection, faricimab-svoa, 0.1 mg
- J2778Injection, ranibizumab, 0.1 mg
- J2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
- J2780Injection, ranitidine hydrochloride, 25 mg
- J2781Injection, pegcetacoplan, intravitreal, 1 mg
- J2782Injection, avacincaptad pegol, 0.1 mg
- J2783Injection, rasburicase, 0.5 mg
- J2785Injection, regadenoson, 0.1 mg
- J2786Injection, reslizumab, 1 mg
- J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
- J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
- J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
- J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
- J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
- J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
- J2793Injection, rilonacept, 1 mg
- J2794Injection, risperidone (risperdal consta), 0.5 mg
- J2795Injection, ropivacaine hydrochloride, 1 mg
- J2796Injection, romiplostim, 10 micrograms
- J2797Injection, rolapitant, 0.5 mg
- J2798Injection, risperidone, (perseris), 0.5 mg
- J2799Injection, risperidone (uzedy), 1 mg
- J2800Injection, methocarbamol, up to 10 ml
- J2801Injection, risperidone (rykindo), 0.5 mg
- J2802Injection, romiplostim, 1 microgram
- J2804Injection, rifampin, 1 mg
- J2805Injection, sincalide, 5 micrograms
- J2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
- J2810Injection, theophylline, per 40 mg
- J2820Injection, sargramostim (gm-csf), 50 mcg
- J2840Injection, sebelipase alfa, 1 mg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
- J2910Injection, aurothioglucose, up to 50 mg
- J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919Injection, methylprednisolone sodium succinate, 5 mg
- J2920Injection, methylprednisolone sodium succinate, up to 40 mg
- J2930Injection, methylprednisolone sodium succinate, up to 125 mg
- J2940Injection, somatrem, 1 mg
- J2941Injection, somatropin, 1 mg
- J2950Injection, promazine hcl, up to 25 mg
- J2993Injection, reteplase, 18.1 mg
- J2995Injection, streptokinase, per 250,000 iu
- J2997Injection, alteplase recombinant, 1 mg
- J2998Injection, plasminogen, human-tvmh, 1 mg